جست‌وجوی استاد و پژوهشگر

• Radiation Biology
• Tumour Microenvironment
• Transcriptional Regulation
• +۳ مورد دیگر

Ejung Moon is a Group Leader in Radiation Biology and the Tumour Microenvironment at the Department of Oncology, University of Oxford's Medical Sciences Division. Her research focuses on hypoxia-driven tumor progression and radiation response mechanisms. Education: PhD in Pharmacology and Cancer Biology from Duke University Training: Postdoctoral work with Amato Giaccia at Stanford University Research Interests: Elucidating how hypoxia-induced MAFF protein regulates tumor cell invasion, metastasis, and radiation resistance through antioxidant response pathways. Current work explores MAFF dimerization dynamics and metabolic reprogramming in hypoxic tumors. Scientific Contributions: Identified MAFF's role in radiation-induced antioxidant gene regulation (2021, Nature Communications ). Recent studies investigate iron metabolism's impact on FLASH radiotherapy effects. Scientific Awards: Breast Cancer Research Program (BCRP) predoctoral fellowship Laboratory & Collaborations: Moon Lab collaborates with Oxford Cancer and NHS Cancer and Haematology Centre. Key partnerships include Stanford University's radiobiology research groups.

• Iron Homeostasis
• Cell Physiology
• Systems Biology
• +۴ مورد دیگر

Dr. Samira Lakhal-Littleton is an Associate Professor of Cell Physiology and MRC Senior Non-Clinical Research Fellow at the University of Oxford, affiliated with the Department of Physiology, Anatomy and Genetics and Brasenose College. Her research focuses on iron homeostasis, systems biology, and oxygen sensing mechanisms in cardiovascular and systemic physiology. Education: BSc in Human Genetics (University College London), DPhil in Molecular Medicine (University of Oxford) Her work bridges cell physiology and translational medicine, with key discoveries on hypoxia-inducible factors (HIFs), iron regulatory genes TMPRSS6 and GDF15 , and the role of hepcidin in altitude adaptation and chronic diseases. She utilizes tissue-specific animal models to study iron regulation in heart, kidney, placenta, and vasculature. Recent publications highlight her contributions to understanding: FLASH radiotherapy effects linked to iron-dependent lipid peroxidation Clinical implications of myocardial iron dynamics in heart failure Hepcidin's role in vascular protection and placental iron transfer Biomarker development for predictive iron deficiency diagnostics Scientific Leadership: British Heart Foundation Intermediate Fellowship (2012) MRC Senior Fellowship (2020) BioIron Society Board Member (2019) She collaborates with clinical teams on translational projects and serves as a Tutorial Fellow in Medicine at Brasenose College, mentoring students in physiological sciences.

Maria Francesca Spadeaمشاهده پروفایل

استاد

• Medical Image Processing
• Artificial Intelligence in Healthcare
• Radiomics
• +۵ مورد دیگر

Prof. Dr.-Ing. Maria Francesca Spadea serves as Director of the Institute of Biomedical Engineering (IBT) at Karlsruhe Institute of Technology (KIT), part of the Helmholtz Association. Her leadership role includes overseeing research initiatives, teaching activities, and administrative responsibilities within the institute. Located in space 512, she maintains regular consultation hours on Wednesdays from 10:30-11:30 am by appointment. Professor Spadea's research spans several cutting-edge areas in biomedical engineering, with particular focus on medical image processing, artificial intelligence applications in healthcare, and radiomics. Her work bridges computational techniques with clinical applications, emphasizing practical solutions for medical imaging challenges. She has pioneered approaches in federated learning for medical image translation, particularly in CT/MRI synthesis for radiation therapy applications. Her research also extends to cancer cell analysis, vascular biomechanics, and medical robotics, demonstrating a broad yet cohesive research portfolio that addresses critical challenges in modern healthcare. Analysis of Professor Spadea's recent publications reveals a strong emphasis on AI-driven medical imaging solutions, particularly in the translation between different imaging modalities (like MRI-to-CT) using federated learning approaches that preserve patient privacy. Her work demonstrates growing specialization in radiation therapy applications, with multiple publications addressing synthetic CT generation for treatment planning. There's also a clear trajectory toward multi-institutional collaboration, as evidenced by her involvement in projects spanning multiple research centers across Europe. Professor Spadea actively mentors numerous students, including M. Krohmer Zabaleta, N. Skupien, and M. Destito, who have completed bachelor's and master's theses under her supervision. Her research group appears well-integrated within the broader Institute of Biomedical Engineering, collaborating extensively with colleagues like P. Zaffino and C.B. Raggio on multiple projects. The group maintains strong connections with clinical partners, as evidenced by publications addressing real-world medical challenges in radiation therapy, cardiology, and neurosurgery. The research activities of Professor Spadea's team are centered within the Institute of Biomedical Engineering at KIT, with particular focus on medical imaging processing and AI applications. Her laboratory appears to specialize in developing computational tools for medical image analysis, with recent work emphasizing privacy-preserving federated learning frameworks that enable multi-institutional collaboration without sharing sensitive patient data. The team maintains active collaborations with clinical departments, particularly in radiation oncology, as evidenced by numerous publications addressing CT synthesis for radiation therapy planning.

Nigel Leeمشاهده پروفایل

مدرس

• Midwifery
• Labour Pain Management
• Sterile Water Injections
• +۷ مورد دیگر

Dr. Nigel Lee is a Lecturer and NHMRC Emerging Leadership Fellow at the University of Queensland's School of Nursing, Midwifery and Social Work. He also serves as an Adjunct Associate Professor with the Molly Wardaguga Research Centre at Charles Darwin University and is affiliated with the Centre for Innovation in Pain and Health Research (CIPHeR). Dr. Lee completed his PhD in 2013 at Australian Catholic University, researching sterile water injections for managing back pain in labour. His research interests span midwifery care, labour pain management, breastfeeding support, perineal trauma prevention, and consent practices during childbirth. He has developed significant expertise in randomized controlled trials and mixed methods research design, with a strong focus on translating research into clinical practice. His recent publications (2023-2025) demonstrate continued productivity across multiple areas of maternal health, with particular emphasis on labour induction trends, breastfeeding education, perineal trauma prevention, and consent practices during labour and birth. These works reflect his commitment to improving evidence-based midwifery practice through rigorous research. Scientific Awards: NHMRC Emerging Leadership Fellow NHMRC Investigator Grant (2023-2027) for 'Water injections: Transforming childbirth pain management for any woman, anywhere' Dr. Lee actively supervises multiple PhD and Master's students across various topics including respectful maternity care, perineal trauma prevention, and breastfeeding support. His current NHMRC-funded projects extend through 2027, demonstrating sustained research productivity. He collaborates extensively with researchers across Australia, Sweden, the UK, and the USA, reflecting his strong international research network. Dr. Lee's work bridges clinical practice and research, with a clear focus on improving maternal health outcomes through evidence-based practice. His leadership in the Consortium for Sterile Water Injections Research and Training (ConSIRT) demonstrates his commitment to translating research findings into practical clinical applications.

• Stem Cell Biology
• Cancer Biology
• Molecular Genetics
• +۳ مورد دیگر

Christopher J. Lengner is the Harriet Ellison Woodward Professor and Chair of the Department of Biomedical Sciences at the University of Pennsylvania School of Veterinary Medicine. He is a member of the Institute for Regenerative Medicine, NIH P30 Center for Molecular Studies in Digestive and Liver Diseases, and Abramson Cancer Center, with roles in training and research leadership. Education : PhD in Cell and Molecular Biology from the University of Massachusetts Medical School (2004). His research focuses on molecular mechanisms governing stem cell potency and their dysregulation in diseases like cancer and regenerative failure. Using genetic, genomic, and single-cell approaches in murine and human systems, his lab has uncovered novel pathways in intestinal stem cell hierarchy, cancer ontogeny, and therapeutic targeting. Recent publications highlight work in colorectal cancer metastasis (PI3K/AKT, NOTUM inhibition), intestinal regeneration (mTORC1, FLASH radiotherapy), and tumor microenvironment dynamics. Collaborations span human induced pluripotent cells and patient samples. Scientific Awards : Ruth L. Kirschstein Postdoctoral Fellowship He mentors graduate students (Ryan Cedeno, Maryam Yousefi) and leads the Center for Animal Transgenesis. His lab’s integrative studies bridge basic science to translational applications in oncology and regenerative medicine.

• Radiation Oncology
• Particle Therapy
• Medical Physics
• +۴ مورد دیگر

Professor J. Debus is a distinguished academic in Radiation Oncology at Heidelberg University's Medical Faculty, with extensive research focused on particle therapy, medical physics, and cancer treatment optimization. His work spans clinical trials, radiobiology, and technical innovations in radiation delivery systems. Primary Affiliation: German Cancer Research Center (DKFZ), Heidelberg Research Focus: Particle therapy, radiation oncology, medical physics Key Collaborations: Mein S., Liew H., Tessonnier T., and other leading researchers in radiation oncology Professor Debus' research interests center on advancing particle therapy techniques including proton, carbon ion, and emerging modalities like helium and oxygen ion therapy. His work addresses critical challenges in radiation oncology such as normal tissue sparing, hypoxia-induced radioresistance, and precision treatment delivery. He has made significant contributions to understanding the biological effects of different radiation types and optimizing treatment protocols for various cancer types including head and neck cancers, brain metastases, and prostate cancer. His recent publications demonstrate leadership in clinical trials (GUARD, ESTRON, PROBASE) and technical innovations in radiation delivery systems, particularly in the emerging field of FLASH radiotherapy and ultra-high dose rate treatments. Professor Debus has published extensively on treatment planning optimization, radiation-induced biological effects, and imaging techniques for precise radiation delivery. Leading clinical trials in particle therapy Developing novel techniques for normal tissue protection Advancing understanding of radiation biology across different modalities Professor Debus has secured significant research funding for his work in radiation oncology and particle therapy. His research has contributed to clinical implementation of advanced treatment techniques at the Heidelberg Ion-Beam Therapy Center (HIT), one of the world's leading facilities for particle therapy. He supervises numerous doctoral students and postdoctoral researchers in the radiation oncology field. His laboratory and research team focus on translational research bridging basic radiobiology with clinical applications, with particular emphasis on optimizing treatment protocols for challenging tumor types and improving patient outcomes through precision radiation therapy.

Francis Cucinottaمشاهده پروفایل

استاد

• Radiation Biology
• Biophysics Modeling
• Space Radiation Health Effects
• +۷ مورد دیگر

Professor Francis Cucinotta is a faculty member at the University of Nevada, Las Vegas, within the Department of Health Physics and Diagnostic Sciences. He teaches radiation biology, dosimetry, and radiation science at both undergraduate and graduate levels. Education: B.S. in Physics (Rutgers University), Ph.D. in Nuclear Physics (Old Dominion University) His research focuses on biophysics models of radiation effects on Earth (e.g., cancer treatment) and in space (e.g., astronaut risk assessment). Key areas include radiation carcinogenesis, neurodegeneration, cataracts, DNA repair, and radiation transport. He has developed theoretical frameworks for nuclear fragmentation, microdosimetry, and systems biology of cell signaling. Recent publications analyze clustered DNA damage, lunar radiation environments, heavy ion therapy, and radiation risk compensation policies. These works span disciplines like biophysics, medical physics, neuroscience, and space systems engineering. Radiation Research Society President (2013-2014) National Council on Radiation Protection and Measurements Council Member Editorial Board Member: Life Sciences in Space Research Guest Editor: Radiation Research, Frontiers in Radiation Oncology Cucinotta has received continuous funding from the National Cancer Institute (2016-2021), with past support from the Department of Energy and NASA. He has authored over 350 peer-reviewed articles and book chapters.

Christine Gustafssonمشاهده پروفایل

استاد

• Health and Welfare Technology (HWT)
• Aging in Place
• Care for Older Adults
• +۳ مورد دیگر

Christine Gustafsson is a Professor in Health Care Sciences at Sophiahemmet University's Department of Nursing. With over 25 years of academic experience, her research focuses on health and welfare technology (HWT) from user perspectives, particularly addressing aging populations and individuals with intellectual disabilities. She leads projects like iHACT, PROTECT, IN-AGE, and UPSCALE, emphasizing technology's role in enabling independent living and safe aging. Professional roles include Nordic Welfare Technology Research Network management, Forte Research Council board membership, and advisory roles to Sweden's Minister of the Elderly and Demensfonden. Education: Not explicitly detailed in provided texts Her research explores HWT implementation challenges in sparsely populated Nordic regions, emphasizing governance structures and user-centered design. Key projects like IN-AGE develop evaluation instruments for technology-supported independence. She co-created the robotic cat JustoCat and authored influential books on pedagogical approaches in care and welfare technology. Recent work analyzes cost-consequence studies of digital assistive technologies and explores FLASH radiotherapy dosimetry challenges. She consistently bridges clinical practice, policy, and technology through interdisciplinary collaboration.

Charles R Thomas Jrمشاهده پروفایل

استاد

• Radiation Oncology
• Clinical and Translational Cancer Research
• Gastrointestinal and Thoracic Malignancies
• +۱۲ مورد دیگر

Charles R. Thomas Jr., MD, is Professor of Medicine and Founding Chair of the Department of Radiation Oncology & Applied Sciences at the Geisel School of Medicine and Dartmouth Cancer Center, a position he began in July 2024. He previously served as Professor and Chair of Radiation Medicine at the Knight Cancer Institute, Oregon Health & Science University. He is Deputy Editor of JAMA Oncology and holds triple-board certification in Radiation Oncology, Medical Oncology, and Internal Medicine. Dartmouth College, BA, 1979 University of Illinois College of Medicine, MD, 1985 Dr. Thomas’s research spans clinical and translational cancer research with emphasis on gastrointestinal and thoracic malignancies, SMMART trials, radiomics, cancer emergency medicine, and health services research in mentorship, diversity, and patient communication. He is deeply committed to academic leadership development and equity in medicine. His recent publications (2024–2025) reflect a strong focus on oncology clinical trial methodology, statistical rigor, research funding trends, and workforce diversity. Themes include proportional hazards violations, secondary endpoint reporting, NIH funding disparities, and gender differences in specialization. His work bridges radiobiology, clinical oncology, and health policy. Scientific awards include: ASTRO Mentoring Award (2022) Dr. Thomas has received funding from the NIH, NSF, foundations, and industry. He actively mentors early-career investigators and has developed mentorship and gender equity toolboxes. He has served on numerous national committees including ASCO, ASTRO, NCI, and the American Board of Radiology. He is the author or co-author of over 360 publications and multiple textbooks. He leads initiatives in mentorship and sponsorship at Dartmouth Cancer Center and previously at OHSU, focusing on pipeline development for underrepresented minorities in radiologic sciences and academic productivity enhancement.

• laser-plasma physics
• laser-driven ion acceleration
• X-ray polarimetry
• +۱ مورد دیگر

Dr. Hans-Peter Schlenvoigt is a researcher at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), working in the Department of Laser Particle Acceleration. His research focuses on experimental and theoretical aspects of high-intensity laser-matter interactions, with emphasis on advancing laser-driven particle acceleration techniques. Research Interests: Dr. Schlenvoigt's work spans laser-plasma physics, laser-driven ion acceleration, X-ray polarimetry, and strong-field quantum electrodynamics. Key themes include: Development of diagnostic methods for relativistic plasmas Optimization of laser-driven proton/ion sources Applications in radiobiology and fundamental physics Advanced laser technologies for extreme conditions Publication Trends: His recent articles (2023-2025) demonstrate a focus on laser-driven particle acceleration mechanisms, plasma diagnostics using X-ray techniques, and quantum electrodynamics in strong fields. The research integrates experimental work at major facilities like J-KAREN-P and theoretical modeling, with growing emphasis on medical applications of laser-accelerated particles. Facilities and Tools: He utilizes HZDR's DRACO-PW laser system and collaborates on projects at international facilities including the Helmholtz International Beamline for Extreme Fields (HIBEF).

Ren, Leiمشاهده پروفایل

استاد

• Image-guided Radiation Therapy
• Artificial Intelligence in Radiotherapy
• Medical Imaging Physics
• +۶ مورد دیگر

Lei Ren, PhD is a Professor and Associate Chief of Physics Research in the Department of Radiation Oncology at the University of Maryland School of Medicine. Previously, he held faculty positions at Duke University Medical Center from 2011-2021, progressing from Assistant Professor to Professor and Director of Physics Research. A clinical medical physicist certified by the American Board of Radiology (ABR), Dr. Ren leads a research program focused on advancing precision radiation therapy through innovative imaging and AI technologies. Dr. Ren's research centers on image-guided radiation therapy (IGRT) and AI applications in radiotherapy. His seminal contributions include developing digital tomosynthesis (DTS) for fast target localization, creating the limited-angle intrafraction verification (LIVE) system, and pioneering cone-beam CT (CBCT) scatter correction methods. Current work focuses on deep learning for deformable image registration, virtual MRI/CBCT generation, XMAN phantom development, and proton dose verification using prompt gamma imaging. His research integrates biomechanical modeling with AI to improve soft tissue contrast and motion management. His 15 most recent publications (2023-2025) reveal a strong trend toward clinical translation of AI in radiation oncology, with emphasis on interpretable AI for clinical decision making, radiomics for cancer prognostics, and novel imaging techniques for proton therapy verification. Approximately 70% of recent work involves deep learning applications, while 30% focuses on advanced imaging physics for motion management and dose verification. Award highlights include: Fellow of the American Association of Physicists in Medicine (AAPM), 2020 Thomas Gorrie Clinical Leadership Impact Award, Duke University, 2019 Top 5 team in AAPM Grand Challenge for 4D-CBCT reconstruction, 2018 Multiple Excellence in Research/Mentorship awards from Duke Medical Physics Program Distinguished Graduate Award from Tsinghua University, 2003 Dr. Ren actively mentors postdoctoral fellows and has secured substantial NIH funding as Principal Investigator for projects including 3D prompt gamma imaging (R01CA279013), XMAN phantoms (R01EB032680), and hybrid virtual-MRI/CBCT systems (R01EB028324). His lab collaborates with industry partners including Varian Medical Systems and ScandiDos AB on clinical implementation of imaging technologies. He serves on NIH study sections and as Deputy Editor for Medical Physics journal. His research group operates within the Radiation Oncology Department's imaging physics division, developing clinical tools for liver SBRT, proton therapy verification, and AI-driven treatment planning. Current projects include FLASH proton therapy dosimetry and virtual clinical trials using XMAN phantoms.

Judith Reindlمشاهده پروفایل

دانشیار

• Particle Radiation Effects
• Radiation Protection
• Cancer Treatment Development
• +۵ مورد دیگر

Judith Reindl is an Associate Professor at the University of Oslo, where she focuses on Biophysics and Medical Physics. Her research integrates fundamental physics with engineering and biomedical applications to study particle radiation effects on biological systems. She is actively investigating particle minibeam and FLASH radiotherapy technologies, radiation protection strategies for space missions (e.g., Mars expeditions), and radiation-hardened electronics for space and fusion technologies. Research Focus: Her interdisciplinary work spans: Radiation impact on cellular structures and organs Development of advanced radiotherapy systems for cancer treatment Space radiation shielding and electronic device resilience Biological experiments elucidating particle radiation mechanisms Publication Trends: Recent articles (2024–2025) emphasize experimental methodologies for radiation research, translational applications of focused ion beams in medicine, and pre-clinical tools for radiotherapy innovation. These reflect her core themes: physics-engineering-biology integration, scalable radiation technologies, and solutions for terrestrial/space challenges.

Mark Oldhamمشاهده پروفایل

استاد

• FLASH radiation therapy
• Radiation and Immunotherapy
• Radiation Therapy Enhanced by Cherenkov photo-Activation (RECA)
• +۶ مورد دیگر

Mark Oldham is Professor of Radiation Oncology and Professor of Physics at Duke University, where he also serves as Director of the Duke Medical Physics MS/PhD Graduate Program and is a Member of the Duke Cancer Institute. His academic career spans over three decades with progressive appointments from Instructor to full Professor in Radiation Oncology. Dr. Oldham received his Ph.D. from Newcastle University (United Kingdom) in 1991. His research interests focus on innovative approaches to radiation therapy, particularly FLASH radiation therapy using the Duke High Intensity Gamma Source (HIGS), radiation and immunotherapy utilizing mini-grids, Radiation Therapy Enhanced by Cherenkov photo-Activation (RECA), and comprehensive 3D dosimetry systems. His work has been recognized with multiple Paper of the Year awards from SEAAPM and the prestigious Farrington Daniel Award from AAPM. His recent publications demonstrate a strong focus on 3D dosimetry systems, radiation therapy verification techniques, and novel cancer treatment approaches. His research integrates advanced dosimetry methods with innovative radiation therapy techniques to improve cancer treatment outcomes. His work on polymer gel dosimetry, optical CT scanning, and radiation-immunotherapy combinations represents cutting-edge developments in the field. Dr. Oldham's scientific achievements have been recognized through multiple awards including the Paper of the Year (2018, 2017), Farrington Daniel Award (2016, 2002), Excellence in Teaching (2014), Excellence in Mentoring (2011), and Fellow of the AAPM (2010). He has also received the Director's Award for Exemplary Service multiple times. As a principal investigator and co-investigator, Dr. Oldham has secured significant research funding from the National Institutes of Health, National Institute of Dental and Craniofacial Research, and Ian's Friends Foundation. His current research portfolio includes exploring synthetic lethality with high energy electron FLASH radiation beams, super-FLASH therapy for pediatric brain tumors, and radiation protection mechanisms. He serves on the Board of Directors of the American Association of Medical Physics and has made significant contributions to medical physics education through his leadership of Duke's Medical Physics Graduate Program.

Sebastiaan Breedveldمشاهده پروفایل

دانشیار

• Radiation Therapy
• Applied Mathematics
• Decision-Making
• +۳ مورد دیگر

Dr. Sebastiaan Breedveld is an Associate Professor in the Department of Radiation Oncology at Erasmus University Medical Center in Rotterdam, The Netherlands. His research focuses on improving radiation therapy through applied mathematics, multi-criteria optimization, and automated treatment planning. He developed the clinically implemented Erasmus-iCycle algorithm and leads projects like TROTS (Radiotherapy Optimisation Test Set). Education includes a PhD in Medical Physics (cum laude) from Erasmus University Rotterdam and an MSc in Applied Mathematics from Delft University of Technology. Research interests center on developing computational methods for real-time, personalized radiotherapy. Key areas include: Large-scale optimization for treatment planning Deep learning for instantaneous dose prediction Multi-criteria decision analysis for balancing treatment trade-offs Proton therapy and VMAT techniques High-performance computing applications Recent publications demonstrate strong focus on AI-driven automation in brachytherapy, IMPT robustness, and FLASH proton therapy. Work consistently addresses clinical translation of mathematical optimization. Significant scientific awards include: NWO Vidi Grant (2021) for INSTORAD project NWO Veni Grant (2016) MCDM Doctoral Dissertation Award (2015) Erasmus MC Efficiency Grant (2015) PhD with honors (2013) Leads research group supervising 2 post-docs, 11 PhD students, and numerous master/bachelor projects. Major grants support work in proton therapy optimization and automated planning systems. Developed TROTS dataset for benchmarking radiotherapy optimization algorithms and collaborates internationally through projects like BiCycle for automated brachytherapy planning.

• Medical Physics
• Radiation Oncology
• Monte Carlo Simulations
• +۵ مورد دیگر

Somayeh Gholami is an Assistant Professor at the University of Utah School of of Medicine and a Medical Physicist in the Department of Radiation Oncology at Huntsman Cancer Hospital. With a PhD in Medical Physics from Tehran University of Medical Sciences and a MSc in Radiation Medicine Engineering from Shahid Beheshti University, she specializes in Monte Carlo simulations for radiotherapy, brachytherapy, grid therapy, and radiobiological modeling. Her work focuses on radiation dose optimization, nanoparticle-enhanced treatments, and advanced dosimetry techniques. Primary affiliation: University of Utah School of Medicine Medical physicist role: Huntsman Cancer Hospital Education: PhD (TUMS), MSc (Shahid Beheshti), BS (Tarbiat Moallem) Residency: University of Arkansas for Medical Sciences (2024) Postdoctoral fellowship: Virginia Commonwealth University Dr. Gholami's research centers on improving radiation therapy through computational modeling (Monte Carlo simulations) and innovative applicator designs. She has developed novel surface brachytherapy molds and direction-modulated brachytherapy tandem applicators, with a particular emphasis on dose distribution optimization and radiobiological modeling. Her work also explores the impact of magnetic fields on radiation parameters and the use of nanoparticles for enhanced treatment efficacy. Recent publications demonstrate trends in Monte Carlo simulations for brachytherapy applications (2025), AI-driven dose distribution prediction (2024-2025), and comparative studies on radiation sources (2023-2024). These works span subfields including medical device design, radiation dosimetry, and computational modeling of biological responses to radiation. U.S. Patent No. 104322 (Surface Mould for Skin Brachytherapy, 2021) U.S. Patent No. 102889 (Respiratory Control Belt, 2020) U.S. Patent No. 103470 (Dynamic Thorax Phantom, 2020) U.S. Patent No. 73752 (Brachytherapy Phantom, 2012) Her clinical research group develops advanced phantoms and dosimetry tools for radiation therapy validation, including 4D XCAT digital phantoms for gated radiotherapy studies and customized 3D printed vaginal templates for adaptive brachytherapy. The team also investigates FLASH radiotherapy efficacy and normal tissue complication probability models for various radiation techniques.